AssetMark Inc
KYNB

AssetMark Inc’s Kyntra Bio KYNB Stock Holding History

AssetMark Inc’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 1387
2021
Q1 		$0 Hold
1
– – ﹤0.01% 1393
2020
Q4 		$0 Hold
1
– – ﹤0.01% 1415
2020
Q3 		$1K Buy
+1
New +$1.08K ﹤0.01% 1222
2020
Q2 		– Hold
0
– – – 1312
2020
Q1 		– Sell
-1
Closed -$994 – 1414
2019
Q4 		$2K Hold
1
– – ﹤0.01% 1232
2019
Q3 		$1K Buy
+1
New +$1.1K ﹤0.01% 1231
2018
Q1 		– Hold
0
– – – 1600
2017
Q4 		– Hold
0
– – – 1950
2017
Q3 		– Hold
0
– – – 1506

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AssetMark Inc's KYNB Position: Q2 2021 in Review

AssetMark Inc sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 1 share.

AssetMark Inc first reported a position in KYNB in Q3 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • AssetMark Inc reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • AssetMark Inc sold 1 Kyntra Bio share in Q2 2021.
  • AssetMark Inc first reported a position in Kyntra Bio in Q3 2019 and held it in 5 quarters.
  • AssetMark Inc's Kyntra Bio position peaked at $2K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on AssetMark Inc's 13F filing for Q2 2021, filed 16 Aug 2021.